Pegah Afra
Overview
Explore the profile of Pegah Afra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
182
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Drees C, Afra P, Verner R, Kaye L, Keith A, Jiang M, et al.
Brain Stimul
. 2024 Mar;
17(2):382-391.
PMID: 38499287
Background: Vagus nerve stimulation (VNS) at low frequencies (≤30 Hz) has been an established treatment for drug-resistant epilepsy (DRE) for over 25 years. Objective: To examine the initial safety and...
2.
Bagic A, Verner R, Afra P, Benbadis S
Epilepsy Behav
. 2023 Jul;
145:109333.
PMID: 37429122
Vagus Nerve Stimulation (VNS) therapy is widely understood to provide clinically meaningful improvements in seizure control to patients with drug-resistant epilepsy, and has been a staple in the clinical armamentaria...
3.
4.
Evolution of the Vagus Nerve Stimulation (VNS) Therapy System Technology for Drug-Resistant Epilepsy
Afra P, Adamolekun B, Aydemir S, Watson G
Front Med Technol
. 2022 Jan;
3:696543.
PMID: 35047938
The vagus nerve stimulation (VNS) Therapy® System is the first FDA-approved medical device therapy for the treatment of drug-resistant epilepsy. Over the past two decades, the technology has evolved through...
5.
Watson G, Afra P, Bartolini L, Graf D, Kothare S, McGoldrick P, et al.
Epilepsy Behav
. 2021 Sep;
124:108319.
PMID: 34563807
Patients often recognize unmet needs that can improve patient-provider experiences in disease treatment management. These needs are rarely captured and may be hard to quantify in difficult-to-treat disease states such...
6.
Eslami V, Stowers J, Afra P, Seifi A
Epilepsy Res
. 2021 Mar;
173:106501.
PMID: 33773308
Objective: In countries where health coverage is not universal, there is ample evidence of disparities in healthcare, often associated with insurance. People with seizures, similar to those living with any...
7.
Zafar S, Aydemir S, Karceski S, Doria J, Schaefer C, Swarnkar R, et al.
J Clin Neurophysiol
. 2021 Feb;
39(7):575-582.
PMID: 33606430
Purpose: Corona virus disease 2019 (COVID-19) refers to coronavirus disease secondary to SARS-CoV2 infection mainly affecting the human respiratory system. The SARS-CoV2 has been reported to have neurotropic and neuroinvasive...
8.
9.
Afra P, Samara V, Fagatele L, Adamolekun B
Epilepsy Behav Case Rep
. 2019 Feb;
11:73-76.
PMID: 30766794
"Burst-suppression" pattern consists of complete attenuation of background between bursts of mixed frequencies, variable morphology and waveforms. It is a subgroup of periodic patterns seen in severe cerebral damage, anesthesia...
10.
Afra P, Bruggers C, Sweney M, Fagatele L, Alavi F, Greenwald M, et al.
Front Hum Neurosci
. 2018 May;
12:171.
PMID: 29780310
Digital health technologies for people with epilepsy (PWE) include internet-based resources and mobile apps for seizure management. Since non-pharmacological interventions, such as listening to specific Mozart's compositions, cognitive therapy, psychosocial...